Karl Hudspith is an associate in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where he is a member of the patents and innovations practice.
Prior to joining the firm, Karl was a postdoctoral fellow at the Wilmer Eye Institute at Johns Hopkins University, where he worked in the lab of Dr. Mandeep Singh to develop a stem cell-based regenerative medicine treatment for inherited retinal degenerations. During his doctoral studies, he helped develop a next-generation sequencing based DNA diagnostic test for patients with inherited retinal degenerations, which was introduced into the UK's National Health Service (NHS) in Oxfordshire, United Kingdom.
Karl Hudspith is an associate in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where he is a member of the patents and innovations practice.
Prior to joining the firm, Karl was a postdoctoral fellow at the Wilmer Eye Institute at Johns Hopkins University, where he worked in the lab of Dr. Mandeep Singh to develop a stem cell-based regenerative medicine treatment for inherited retinal degenerations. During his doctoral studies, he helped develop a next-generation sequencing based DNA diagnostic test for patients with inherited retinal degenerations, which was introduced into the UK's National Health Service (NHS) in Oxfordshire, United Kingdom.